arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Revvity, Inc.

RVTY Industrials Biotechnology: Laboratory Analytical Instruments
$157.36
▲ +0.9% Today
as of Oct 22, 16:52 ET
Last 30 days +22.47% Sep 14 → Oct 22
$126.18 $134.55 $142.93 $151.30 $159.67 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$156.18
High
$161.52
Low
$154.88
Volume
$2M
Avg Vol
$2M
Mkt Cap
$17.1B
P/E (TTM)
124.10
Beta
—
52w High
$166.25
52w Low
$81.22
Div Yield
—
Shares Out
$112M

Recent Press Releases & News last 60 days · 25 items

Oct 22 · 13:34 Zacks
Revvity Launches Signals LabGistics to Coordinate Scientific Workflows
Oct 20 · 12:00 PR Business Wire
Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows
Oct 16 · 11:02 GuruFocus.com
ETFs Are Net Sellers of Revvity (RVTY) on Wednesday
▸ Show all 25 press releases & news Free account →

RVTY earnings at a glance

Revvity, Inc. (RVTY) is scheduled to report earnings on Tuesday, November 3, 2026 before the market opens — in 11 days. Analysts expect earnings per share of $1.29, compared with $1.18 in the same quarter last year (+9%). The options market is pricing a move of about ±5.9% after the report, a range of roughly $148.10 to $166.62 from today's $157.36. Over its last 6 reports the stock rose the next day 2 times and fell 4, moving ±3.7% on average; after the most recent report on Aug 4, 2026 it moved -3.3%. That means options currently expect more movement than RVTY has typically delivered. RVTY beat the consensus EPS estimate in 6 of its last 6 reported quarters. Implied volatility is currently 50%. The share price of $157.36 sits near its 52-week high.

More Industrials stocks · All stocks · Earnings calendar

Overview

52-week range
$81
$166
90% of range
Avg surprise (last 6)
+6.3%
Avg reaction (last 6)
-1.2%
33% positive
Latest IV / EM
50%
EM ±5.9% · $150 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.08$1.19$2.29$3.40$4.50 Actual $4.50Actual $0.28Actual $0.08Actual $0.21Actual $0.45Actual $0.77Actual $1.01Est $0.96Actual $1.18Est $1.14Actual $1.18Est $1.14Actual $1.70Est $1.59Actual $1.06Est $1.02Actual $1.41Est $1.23 AprJulOctMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$0$192M$383M$575M$766M Sep 24Mar 25Jun 25Sep 25Apr 26Jul 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Aug 4, 2026Jun/2026 $1.41 $1.23 +14.6% +4.2% -3.3% earnings
Tue May 5, 2026Mar/2026 $1.06 $1.02 +3.9% +5.0% +6.7% earnings
Mon Feb 2, 20268K 2026-02-02 $1.70 $1.59 +6.9% — -1.6% earnings
Mon Oct 27, 2025Sep/2025 $1.18 $1.14 +3.5% — -1.7% earnings
Mon Jul 28, 2025Jun/2025 $1.18 $1.14 +3.5% — -8.3% earnings
Mon Apr 28, 2025Mar/2025 $1.01 $0.96 +5.2% — +0.8% earnings
Sun Sep 29, 2024Sep 2024 $0.77 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.45 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.21 — — — — financials
Sun Oct 1, 2023Oct 2023 $0.08 — — — — financials
Sun Jul 2, 2023Jul 2023 $0.28 — — — — financials
Sun Apr 2, 2023Apr 2023 $4.50 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Nov 3, 2026Sep/2026BMO $1.29$1.18 +9.3%

Financials

Income statement (quarterly)

MetricJul 2026Apr 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$730M$711M—$699M$720M$665M—$684M
Cost of revenue$313M$323M—$324M$328M$289M—$299M
Gross profit————————
Operating income$89M$76M—$82M$91M$72M—$98M
Net income$52M$41M—$47M$54M$42M—$94M
EPS (diluted)$0.47$0.36—$0.40$0.46$0.35—$0.77

Balance sheet (quarterly)

MetricJul 2026Apr 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$1.02B$860M$920M$931M$992M$1.14B$1.16B$1.23B
Inventory$379M$388M$379M$380M$388M$381M$368M$405M
Total current assets$2.30B$2.13B$2.24B$2.14B$2.24B$2.32B$2.35B$2.45B
Total assets$12.05B$12.00B$12.17B$12.14B$12.36B$12.36B$12.39B$12.77B
Long-term debt$2.63B$2.63B$2.63B$2.63B$3.21B$3.17B$3.15B$3.19B
Total liabilities$4.82B$4.81B$4.92B$4.76B$4.81B$4.72B$4.73B$4.85B
Total equity$7.23B$7.18B$7.25B$7.38B$7.56B$7.64B$7.67B$7.92B

Implied volatility — last 90 days

34%56%78%100%122% Jun 07 — IV 48% · EM ±6.6%Jun 08 — IV 45% · EM ±5.9%Jun 09 — IV 48% · EM ±6.0%Jun 10 — IV 51% · EM ±6.1%Jun 11 — IV 49% · EM ±5.4%Jun 12 — IV 38% · EM ±3.9%Jun 15 — IV 48% · EM ±3.5%Jun 16 — IV 67% · EM ±4.0%Jun 17 — IV 122% · EM ±5.1%Jun 19 — IV 44% · EM ±9.8%Jun 22 — IV 46% · EM ±9.6%Jun 23 — IV 45% · EM ±9.2%Jun 24 — IV 43% · EM ±8.7%Jun 25 — IV 46% · EM ±8.9%Jun 26 — IV 43% · EM ±8.3%Jun 29 — IV 45% · EM ±8.0%Jun 30 — IV 42% · EM ±7.3%Jul 01 — IV 42% · EM ±7.1%Jul 02 — IV 43% · EM ±6.9%Jul 03 — IV 44% · EM ±6.9%Jul 06 — IV 45% · EM ±6.3%Jul 07 — IV 48% · EM ±6.4%Jul 08 — IV 47% · EM ±5.9%Jul 09 — IV 46% · EM ±5.4%Jul 10 — IV 50% · EM ±5.5%Jul 13 — IV 50% · EM ±4.2%Jul 14 — IV 61% · EM ±4.4%Jul 15 — IV 63% · EM ±3.7%Jul 16 — IV 80% · EM ±3.3%Jul 20 — IV 51% · EM ±12.0%Jul 21 — IV 50% · EM ±11.7%Jul 22 — IV 51% · EM ±11.8%Jul 23 — IV 49% · EM ±11.0%Jul 24 — IV 50% · EM ±11.0%Jul 27 — IV 55% · EM ±11.5%Jul 28 — IV 53% · EM ±10.9%Jul 29 — IV 48% · EM ±9.7%Jul 30 — IV 51% · EM ±10.0%Jul 31 — IV 53% · EM ±10.2%Aug 03 — IV 54% · EM ±9.6%Aug 04 — IV 42% · EM ±7.3%Aug 05 — IV 41% · EM ±6.9%Aug 06 — IV 42% · EM ±6.9%Aug 07 — IV 43% · EM ±6.7%Aug 10 — IV 43% · EM ±5.9%Aug 11 — IV 45% · EM ±5.9%Aug 12 — IV 41% · EM ±5.2%Aug 13 — IV 44% · EM ±5.2%Aug 14 — IV 42% · EM ±4.6%Aug 17 — IV 45% · EM ±3.8%Aug 18 — IV 49% · EM ±3.5%Aug 19 — IV 51% · EM ±3.0%Aug 20 — IV 62% · EM ±2.6%Aug 24 — IV 40% · EM ±8.3%Aug 25 — IV 39% · EM ±7.9%Aug 26 — IV 37% · EM ±7.4%Aug 27 — IV 35% · EM ±6.8%Aug 28 — IV 35% · EM ±6.6%Aug 31 — IV 34% · EM ±6.0%Sep 01 — IV 37% · EM ±6.4%Sep 02 — IV 35% · EM ±5.9%Sep 03 — IV 36% · EM ±5.8%Sep 04 — IV 35% · EM ±5.5%Sep 07 — IV 39% · EM ±5.5%Sep 08 — IV 48% · EM ±6.3%Sep 09 — IV 47% · EM ±5.9%Sep 10 — IV 43% · EM ±5.0%Sep 11 — IV 44% · EM ±4.8%Sep 14 — IV 55% · EM ±4.6%Sep 15 — IV 63% · EM ±4.5%Sep 16 — IV 63% · EM ±3.7%Sep 17 — IV 69% · EM ±2.9%Sep 21 — IV 38% · EM ±8.0%Sep 22 — IV 39% · EM ±8.0%Sep 23 — IV 37% · EM ±7.3%Sep 24 — IV 43% · EM ±8.4%Sep 25 — IV 39% · EM ±7.4%Sep 28 — IV 43% · EM ±7.7%Sep 29 — IV 42% · EM ±7.2%Sep 30 — IV 43% · EM ±7.2%Oct 01 — IV 42% · EM ±6.7%Oct 02 — IV 41% · EM ±6.5%Oct 06 — IV 49% · EM ±6.5%Oct 07 — IV 48% · EM ±6.1%Oct 08 — IV 50% · EM ±5.9%

Sector peers

AVTR
Avantor, Inc.
$10.4B $17.15+3.2%
TXG
10x Genomics, Inc.
$9.9B $69.75-2.4%
BIO
Bio-Rad Laboratories, Inc.
$9.8B $363.50+2.5%
BRKR
Bruker Corporation
$9.1B $57.31+2.5%
MTD
Mettler-Toledo International, Inc.
$30.7B $1,684.64+3.1%
ALMR
Alamar Biosciences, Inc.
$1.9B $29.72+5.5%

RVTY earnings FAQ

When is RVTY's next earnings date?

Revvity, Inc. is expected to report on November 3, 2026, before the market opens.

What is RVTY's expected move for earnings?

Options currently price a move of about ±5.9%, or $9.26 per share either way from $157.36.

How does RVTY stock usually react to earnings?

Across the last 6 reports the average next-day move was ±3.7%, up 2 times and down 4 times.

What EPS are analysts expecting from Revvity, Inc.?

The consensus estimate is $1.29 per share, versus $1.18 a year ago.

What is RVTY's implied volatility?

RVTY's at-the-money implied volatility is about 50% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in